ArticleJournal of applied clinical medical physics2020
Deep learning-based survival analysis for brain metastasis patients with the national cancer database.
Article in Journal of applied clinical medical physics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Dynamic Prediction of Clinical Endpoints in Survival Analysis With Machine and Deep Learning: A Systematic Review and Regulatory Perspective.CPT: pharmacometrics & systems pharmacology · 2026Pooled it
- A Systematic Review on Machine Learning Techniques for Survival Analysis in Cancer.Cancer medicine · 2025Pooled it
- Causality-Guided Machine Learning for Retinoblastoma Survival Prediction: Development and Comparative Evaluation Using SEER.Medical sciences (Basel, Switzerland) · 2026Article
- Machine Learning Models for Disease-Free Survival Analysis after Liver Resection for Hepatocellular Carcinoma: A Multicentric French Collaborative Study.Liver cancer · 2026Article
- Emerging Trends in Artificial Intelligence in Neuro-Oncology.Current oncology reports · 2025Review
- Unsupervised Clustering Successfully Predicts Prognosis in NSCLC Brain Metastasis Cohorts.Diagnostics (Basel, Switzerland) · 2025Article
- Machine learning in image-based outcome prediction after radiotherapy: A review.Journal of applied clinical medical physics · 2025Review
- The velocity of temporalis muscle wasting in cerebral metastasis is prognostic for poor survival.Frontiers in oncology · 2025Article
- Case-Base Neural Network: Survival analysis with time-varying, higher-order interactions.Machine learning with applications · 2024Article
- Use of survival support vector machine combined with random survival forest to predict the survival of nasopharyngeal carcinoma patients.Translational cancer research · 2023Article
- Predicting peritumoral edema development after gamma knife radiosurgery of meningiomas using machine learning methods: a multicenter study.European radiology · 2023Article
- A novel staging system based on deep learning for overall survival in patients with esophageal squamous cell carcinoma.Journal of cancer research and clinical oncology · 2023Article
- Deep Learning-Based Time-to-Death Prediction Model for COVID-19 Patients Using Clinical Data and Chest Radiographs.Journal of digital imaging · 2023Article
- Predicting Survival in Patients with Brain Tumors: Current State-of-the-Art of AI Methods Applied to MRI.Diagnostics (Basel, Switzerland) · 2022Review
- Applying Artificial Neural Networks to Develop a Decision Support Tool for Tis-4N0M0 Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy.JCO clinical cancer informatics · 2022Article
- A novel risk classification system based on the eighth edition of TNM frameworks for esophageal adenocarcinoma patients: A deep learning approach.Frontiers in oncology · 2022Article
- An automated approach for predicting glioma grade and survival of LGG patients using CNN and radiomics.Frontiers in oncology · 2022Article
- An energy-efficient in-memory computing architecture for survival data analysis based on resistive switching memories.Frontiers in neuroscience · 2022Article
- Machine Learning Incorporating Host Factors for Predicting Survival in Head and Neck Squamous Cell Carcinoma Patients.Cancers · 2021Article
- Prognostic risk stratification of gliomas using deep learning in digital pathology images.Neuro-oncology advancesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePrognostic indices such as the Brain Metastasis Graded Prognostic Assessment have been used in clinical settings to aid physicians and patients in determining an appropriate treatment regimen. These indices are derivative of traditional survival analysis techniques such as Cox proportional hazards (CPH) and recursive partitioning analysis (RPA). Previous studies have shown that by evaluating CPH risk with a nonlinear deep neural network, DeepSurv, patient survival can be modeled more accurately. In this work, we apply DeepSurv to a test case: breast cancer patients with brain metastases who have received stereotactic radiosurgery.
methodsSurvival times, censorship status, and 27 covariates including age, staging information, and hormone receptor status were provided for 1673 patients by the NCDB. Monte Carlo cross-validation with 50 samples of 1400 patients was used to train and validate the DeepSurv, CPH, and RPA models independently. DeepSurv was implemented with L2 regularization, batch normalization, dropout, Nesterov momentum, and learning rate decay. RPA was implemented as a random survival forest (RSF). Concordance indices of test sets of 140 patients were used for each sample to assess the generalizable predictive capacity of each model.
resultsFollowing hyperparameter tuning, DeepSurv was trained at 32 min per sample on a 1.33 GHz quad-core CPU. Test set concordance indices of 0.7488 ± 0.0049, 0.6251 ± 0.0047, and 0.7368 ± 0.0047, were found for DeepSurv, CPH, and RSF, respectively. A Tukey HSD test demonstrates a statistically significant difference between the mean concordance indices of the three models.
conclusionOur results suggest that deep learning-based survival prediction can outperform traditional models, specifically in a case where an accurate prognosis is highly clinically relevant. We recommend that where appropriate data are available, deep learning-based prognostic indicators should be used to supplement classical statistics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.